Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ReNeuron Group Plc logo — Developing the next generation of Engineered Exosomes.

ReNeuron Group Plc

Developing the next generation of Engineered Exosomes.

Founded 1997 United Kingdom Bridgend, United Kingdom 27 employees Post Ipo Equity Total: $110.95M Biotechnology, Health Care +1

General Information

Company Name ReNeuron Group Plc
Founded Year 1997
Location United Kingdom Bridgend, United Kingdom +1
Founders / Decision Makers
Team member
Employees 27
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when ReNeuron Group Plc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ReNeuron Group Plc

ReNeuron Group Plc is a biotechnology startup based in United Kingdom that is dedicated to developing the next generation of Engineered Exosomes. The company's flagship technology, CustomEx exosome platform, is designed to produce exosomes with unique tissue targeting tropisms, allowing for the delivery of a payload of choice to a preferred cell type. ReNeuron's ultimate mission is to partner and develop novel exosome therapeutics for diseases with significant unmet needs in the fields of Biotechnology and Health Care. Founded in 1997, ReNeuron Group Plc has garnered significant attention from investors. Its last investment of £68.40MPost-IPO Equity was secured on 10 July 2015 from a notable investor, Woodford Patient Capital Trust. This infusion of capital underscores the growing interest in ReNeuron's innovative approach to addressing unmet medical needs through exosome therapeutics. With a clear focus on leveraging its proprietary technology to advance the field of regenerative medicine, ReNeuron holds promise as a key player in the biotech landscape.

Taxonomy: Exosome technology, CustomEx platform, Tissue targeting, Payload delivery, Cell-specific targeting, Therapeutic development, Disease treatment, Partnership, Drug delivery, Regenerative medicine

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1
Investor
10 Jul 2015
Post-IPO Equity •••••• 1
Investor
22 Jul 2013
Post-IPO Equity •••••• - 22 Feb 2010
Post-IPO Equity •••••• 1 •••• •••• 26 Nov 2009
Venture Round •••••• 1
Investor
01 Jan 1997

ReNeuron Group Plc Alternatives & Competitors

ReNeuron Group Plc vs
Mantra Bio
Mantra Bio United States

Mantra Bio is harnessing exosomes to deliver safe, highly targeted medicines.

Series A
14 employees
Biotechnology, Life Sciences
Compare ReNeuron Group Plc vs Mantra Bio
ReNeuron Group Plc vs
Exopharm Ltd
Exopharm Ltd Australia

Delivering Transformative Medicines

5 employees
Biopharma, Biotechnology
ReNeuron Group Plc vs
Evox Therapeutics Ltd
Evox Therapeutics Ltd United Kingdom

Changing the course of CNS disease

Series C
39 employees
Biotechnology, Health Care
Compare ReNeuron Group Plc vs Evox Therapeutics Ltd
Also compare with: ReNeuron Group Plc vs Primoris Co., Ltd. Primoris Co., Ltd.

FAQ About ReNeuron Group Plc

Developing the next generation of Engineered Exosomes.
ReNeuron Group Plc was founded in 1997.
ReNeuron Group Plc is headquartered in Bridgend, United Kingdom.
ReNeuron Group Plc operates in the following industries: Biotechnology, Health Care, Health and Wellness.
ReNeuron Group Plc has approximately 27 employees.
ReNeuron Group Plc has completed 5 funding rounds, raising a total of $110.95M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to ReNeuron Group Plc include Mantra Bio, Exopharm Ltd, Evox Therapeutics Ltd, Primoris Co., Ltd., EXOCAN HEALTHCARE TECHNOLOGIES. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ReNeuron Group Plc and Mantra Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ReNeuron Group Plc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy